AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8579029 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker therapy
Number of subjects: 15
Study 1859762 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopentone 5 mg kg‐1
Number of subjects: 0
Study 1859762 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 mg kg‐1
Number of subjects: 0
Study 6811237 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 g human immunoglobulin i.v. over four months
Number of subjects: 98
Study 6811237 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusions (control group) averaging 4.4 units per patient
Number of subjects: 98
Study 6811237 — intervention group
Group type: COMPARATOR
Intervention: Blood transfusions (control group)
Number of subjects: 98
Study 31196147 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bout of aerobic exercise for 30 minutes at 80% individual anaerobic threshold
Number of subjects: 92
Study 31196147 — intervention group
Group type: COMPARATOR
Intervention: Control group (sitting and reading for 30 minutes)
Number of subjects: 92
Study 28902927 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min of exercise performed at 120% of lactate threshold (120%LT)
Number of subjects: 11
Study 28902927 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min of exercise performed at 80% of lactate threshold (80%LT)
Number of subjects: 11
Study 28902927 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 11
Study 25585514 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective-LEDT
Number of subjects: 1
Study 25585514 — intervention group
Group type: COMPARATOR
Intervention: Placebo-1-LEDT
Number of subjects: 1
Study 25585514 — intervention group
Group type: COMPARATOR
Intervention: Placebo-2-LEDT
Number of subjects: 1
Study 23497465 — intervention group
Group type: EXPERIMENTAL
Intervention: Best medical care plus intermittent pneumatic compression (IPC)
Number of subjects: 2876
Study 23497465 — intervention group
Group type: COMPARATOR
Intervention: Best medical care
Number of subjects: 2876
Study 23497465 — intervention group
Group type: EXPERIMENTAL
Intervention: Best medical care plus IPC
Number of subjects: 2876
Study 21310051 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron syrup (0.15 mg/Kg of body weight)
Number of subjects: 540
Study 21310051 — intervention group
Group type: EXPERIMENTAL
Intervention: domperidone syrup (0.5 mg/Kg of body weight)
Number of subjects: 540
Study 21310051 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 540
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: NYHA class >II
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous or inducible VT as indication for ICD therapy
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of amiodarone
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced age
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal failure
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of digitalis
Number of subjects: 822
Study 19797255 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of diuretics
Number of subjects: 822
Study 16881807 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06% chlorhexidine and 0.025% fluoride mouthrinse
Number of subjects: 156
Study 16881807 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% cetylpyridiniumchloride and 0.025% fluoride mouthrinse
Number of subjects: 156
Study 16881807 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental floss
Number of subjects: 156
Study 16881807 — intervention group
Group type: COMPARATOR
Intervention: Toothbrushing only
Number of subjects: 156
Study 14709577 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal ziconotide
Number of subjects: 111
Study 14709577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 11886028 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 21
Study 11886028 — intervention group
Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 21
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 mg/d transdermal nicotine
Number of subjects: 70
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: 22 mg/d transdermal nicotine
Number of subjects: 70
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: 44 mg/d transdermal nicotine
Number of subjects: 70
Study 9462489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 70
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 70
Study 9462489 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous abstainers (21 subjects)
Number of subjects: 70
Study 7832596 — intervention group
Group type: EXPERIMENTAL
Intervention: Management of behavioral manifestations of dementia
Number of subjects: 0
Study 1970466 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine, 200 mg orally every 4 hours
Number of subjects: 711
Study 1970466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 711
Study 154492 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (80 microgram)
Number of subjects: 10
Study 154492 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6861859 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release furosemide
Number of subjects: 18
Study 6861859 — intervention group
Group type: COMPARATOR
Intervention: Standard formulation of furosemide
Number of subjects: 18
Study 6861859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6861859 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 18
Study 6861859 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium excretion
Number of subjects: 18
Study 30194887 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified mother's milk (FHM)
Number of subjects: 281
Study 30194887 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm formula (PF)
Number of subjects: 281
Study 30194887 — intervention group
Group type: COMPARATOR
Intervention: Unfortified mother's milk (UHM)
Number of subjects: 281
Study 30044241 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate (15mg/kg, equivalent to 7.5mg/kg of caffeine base)
Number of subjects: 8
Study 30044241 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 8
Study 30044241 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate
Number of subjects: 8
Study 27903345 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 kV CT angiography with 0.8 ml/kg contrast agent
Number of subjects: 200
Study 27903345 — intervention group
Group type: COMPARATOR
Intervention: 120 kV CT angiography with 100 ml contrast agent
Number of subjects: 200
Study 25445073 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based therapy with safety behavior assessment
Number of subjects: 268
Study 25445073 — intervention group
Group type: EXPERIMENTAL
Intervention: Texas Safety Maneuver Scale (TSMS)
Number of subjects: 268
Study 25445073 — intervention group
Group type: COMPARATOR
Intervention: Exposure-based therapy
Number of subjects: 268
Study 22178539 — intervention group
Group type: EXPERIMENTAL
Intervention: Neridronate 12.5 mg
Number of subjects: 107
Study 22178539 — intervention group
Group type: EXPERIMENTAL
Intervention: Neridronate 25 mg
Number of subjects: 107
Study 22178539 — intervention group
Group type: EXPERIMENTAL
Intervention: Neridronate 50 mg
Number of subjects: 107
Study 22178539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 21130385 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab (minimum, 0.016 mg/kg/IU (IgE/mL) every 4 weeks)
Number of subjects: 1071
Study 21130385 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1071
Study 21130385 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 1071
Study 18637638 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 100
Study 18637638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 15383747 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine (6-12 mg/day)
Number of subjects: 44
Study 15383747 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 15383747 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 44
Study 12413703 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytodrug (QG-5) from guava leaves, 500 mg capsules administered every 8 hours for 3 days
Number of subjects: 50
Study 10527973 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA) plus paracervical block (PCB)
Number of subjects: 150
Study 10527973 — intervention group
Group type: COMPARATOR
Intervention: Alfentanil plus paracervical block (PCB)
Number of subjects: 150
Study 8846250 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol drops
Number of subjects: 37
Study 8846250 — intervention group
Group type: COMPARATOR
Intervention: Placebo drops
Number of subjects: 37
Study 2109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam for anxiety relief during radial keratotomy
Number of subjects: 3
Study 2109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam with low doses of phenoperidine for sedation and amnesia during cataract surgery
Number of subjects: 3
Study 2109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam combined with fentanyl and vecuronium for general anaesthesia in elderly patients
Number of subjects: 3
Study 2109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam to decrease intraocular pressure
Number of subjects: 3
Study 2109467 — intervention group
Group type: EXPERIMENTAL
Intervention: Flumazenil to antagonise midazolam effects
Number of subjects: 3
Study 7247000 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg piritramide
Number of subjects: 36
Study 7247000 — intervention group
Group type: COMPARATOR
Intervention: 0.003 mg/kg fentanyl
Number of subjects: 36
Study 7247000 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal circulation
Number of subjects: 36
Study 31542090 — intervention group
Group type: EXPERIMENTAL
Intervention: Taiwan Smoker's Helpline (TSH)
Number of subjects: 68
Study 29131352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ethanol infusion at 100 mg%
Number of subjects: 93
Study 29131352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ethanol infusion at higher doses
Number of subjects: 93
Study 26291199 — intervention group
Group type: EXPERIMENTAL
Intervention: Selexipag (compound 26a)
Number of subjects: 0
Study 24831989 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified insulin-based glycaemic control for at least 3 months
Number of subjects: 620
Study 24831989 — intervention group
Group type: COMPARATOR
Intervention: Conventional glucose-lowering treatment (Control)
Number of subjects: 620
Study 22628108 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 days per week training frequency
Number of subjects: 12
Study 22628108 — intervention group
Group type: COMPARATOR
Intervention: 5 days per week training frequency
Number of subjects: 12
Study 22628108 — intervention group
Group type: EXPERIMENTAL
Intervention: Both training frequencies (3 days and 5 days per week)
Number of subjects: 12
Study 19361029 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote-mounted perfusion system
Number of subjects: 4
Study 17324253 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine acupuncture-care and self-care (10 sessions over 12 weeks)
Number of subjects: 286
Study 17324253 — intervention group
Group type: COMPARATOR
Intervention: Self-care only (control group)
Number of subjects: 286
Study 17324253 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine acupuncture-care and self-care
Number of subjects: 286
Study 15364757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation program
Number of subjects: 1218
Study 15364757 — intervention group
Group type: COMPARATOR
Intervention: Hospitalization in the prior 3 months
Number of subjects: 1218
Study 15364757 — intervention group
Group type: EXPERIMENTAL
Intervention: General QOL measures
Number of subjects: 1218
Study 15364757 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-specific QOL measures
Number of subjects: 1218
Study 11445753 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise treatment group, met three times/week throughout the study
Number of subjects: 308
Study 11445753 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise treatment group
Number of subjects: 308
Study 9692123 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol 12 micrograms b.i.d.
Number of subjects: 262
Study 9692123 — intervention group
Group type: EXPERIMENTAL
Intervention: formoterol 24 micrograms b.i.d.
Number of subjects: 262
Study 9692123 — intervention group
Group type: COMPARATOR
Intervention: salbutamol 400 micrograms q.i.d.
Number of subjects: 262
Study 8209977 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous flow continuous positive airways pressure system
Number of subjects: 10
Study 8209977 — intervention group
Group type: COMPARATOR
Intervention: Demand valve system of the Engstrom Erica ventilator
Number of subjects: 10
Study 3791601 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol
Number of subjects: 40
Study 3791601 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 31996334 — intervention group
Group type: EXPERIMENTAL
Intervention: Clipping of aneurysms aided by transit time flowmetry
Number of subjects: 0
Study 31359357 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 160 mg daily
Number of subjects: 46
Study 31359357 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 25919112 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (1000 μg daily) for 4 weeks
Number of subjects: 246
Study 25919112 — intervention group
Group type: EXPERIMENTAL
Intervention: rs7772821 (T>G) polymorphism
Number of subjects: 246
Study 23414637 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer coaching program including a coach and reminders by well-trained volunteers, three home visits and five telephone calls over a two-month period
Number of subjects: 62
Study 23414637 — intervention group
Group type: COMPARATOR
Intervention: Routine care alone
Number of subjects: 62
Study 23414637 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer coaching program
Number of subjects: 62
Study 22194988 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose flutamide, metformin, and pioglitazone in combination with an estro-progestagen
Number of subjects: 0
Study 19348959 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep (overnight sleep)
Number of subjects: 0
Study 19348959 — intervention group
Group type: COMPARATOR
Intervention: Daytime wakefulness (control)
Number of subjects: 0
Study 19348959 — intervention group
Group type: EXPERIMENTAL
Intervention: Nap study (sleep)
Number of subjects: 0
Study 19348959 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep, slow-wave sleep (SWS)
Number of subjects: 0
Study 16521013 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior soft tissue repair
Number of subjects: 33
Study 16521013 — intervention group
Group type: COMPARATOR
Intervention: No posterior soft tissue repair
Number of subjects: 33
Study 16521013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (with and without posterior soft tissue repair)
Number of subjects: 33
Study 15340334 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 113
Study 15340334 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 113
Study 15340334 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 113
Study 15340334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 113
Study 11169056 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2a 6 million units three times weekly plus ribavirin 14 mg/kg per day (n=93)
Number of subjects: 185
Study 9166306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal monitor cystometrogram
Number of subjects: 66
Study 9166306 — intervention group
Group type: COMPARATOR
Intervention: Multichannel electronic cystometer
Number of subjects: 66
Study 8250106 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinine (17 mg/kg over 4.5 hr)
Number of subjects: 12
Study 8250106 — intervention group
Group type: COMPARATOR
Intervention: Quinine alone
Number of subjects: 12
Study 8250106 — intervention group
Group type: EXPERIMENTAL
Intervention: Prochlorperazine (12.5 mg intramuscularly)
Number of subjects: 12
Study 3903529 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 11
Study 3903529 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulindac
Number of subjects: 11
Study 3903529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30230694 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cabotegravir 30 mg after a high-fat meal (∼53% fat, ∼870 kcal)
Number of subjects: 24
Study 30230694 — intervention group
Group type: COMPARATOR
Intervention: Oral cabotegravir 30 mg after fasting
Number of subjects: 24
Study 27547853 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Adaptation Training (CAT) guide
Number of subjects: 17
Study 27547853 — intervention group
Group type: COMPARATOR
Intervention: Support-manual
Number of subjects: 17
Study 25901097 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 68
Study 25901097 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle modification and intensive medical management (LS/IMM)
Number of subjects: 68
Study 25901097 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) and Lifestyle modification and intensive medical management (LS/IMM)
Number of subjects: 68
Study 22431305 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 111
Study 22431305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 111
Study 22431305 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 111
Study 21952346 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-in-1 perineal care washcloth impregnated with 3% dimethicone
Number of subjects: 141
Study 21952346 — intervention group
Group type: COMPARATOR
Intervention: Water and pH neutral soap (control)
Number of subjects: 141
Study 19250003 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous micronutrient therapy (IVMT)
Number of subjects: 34
Study 19250003 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactated Ringer's solution)
Number of subjects: 34
Study 17827929 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (2.5 mg daily for 48 weeks)
Number of subjects: 12
Study 17827929 — intervention group
Group type: COMPARATOR
Intervention: Alfacalcidol (0.5 microg daily for 48 weeks)
Number of subjects: 12
Study 17827929 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 12
Study 14644064 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of hydrocortisone
Number of subjects: 0
Study 14644064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11479846 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrogastrography (EGG) in patients who underwent GCP
Number of subjects: 25
Study 11479846 — intervention group
Group type: COMPARATOR
Intervention: Electrogastrography (EGG) in normal subjects
Number of subjects: 25
Study 8151592 — intervention group
Group type: EXPERIMENTAL
Intervention: specially trained physical therapists (PT)
Number of subjects: 54
Study 8151592 — intervention group
Group type: COMPARATOR
Intervention: traditional physical therapists (PT)
Number of subjects: 54
Study 2901818 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2901818 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (100 mg twice daily)
Number of subjects: 30
Study 2901818 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg twice daily)
Number of subjects: 30
Study 29160551 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates group (n=20)
Number of subjects: 56
Study 29160551 — intervention group
Group type: COMPARATOR
Intervention: Yoga group (n=18)
Number of subjects: 56
Study 29160551 — intervention group
Group type: COMPARATOR
Intervention: Isometric group (n=18)
Number of subjects: 56
Study 28061372 — intervention group
Group type: EXPERIMENTAL
Intervention: Beat gestures present during word recall
Number of subjects: 106
Study 28061372 — intervention group
Group type: COMPARATOR
Intervention: No beat gestures present during word recall
Number of subjects: 106
Study 26019023 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat spread enriched with plant sterols (PS) and eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at doses of 0.0, 0.9, 1.3, and 1.8 g/day for 4 weeks
Number of subjects: 282
Study 26019023 — intervention group
Group type: COMPARATOR
Intervention: Placebo spread
Number of subjects: 282
Study 22366739 — intervention group
Group type: COMPARATOR
Intervention: GT with skimmed milk (GT + M)
Number of subjects: 24
Study 22366739 — intervention group
Group type: COMPARATOR
Intervention: GT with caseinate (GT + CS)
Number of subjects: 24
Study 22366739 — intervention group
Group type: COMPARATOR
Intervention: GT with soy protein (GT + S)
Number of subjects: 24
Study 21452357 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PEMF treatment (pulsing electromagnetic field) worn on the distal forearm for 1, 2, or 4 hours/day for 8 weeks.
Number of subjects: 99
Study 21452357 — intervention group
Group type: COMPARATOR
Intervention: Sham PEMF treatment (identical sham transducers) worn on the distal forearm for 1, 2, or 4 hours/day for 8 weeks.
Number of subjects: 99
Study 21452357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both active and sham PEMF treatments.
Number of subjects: 99
Study 18472364 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity‐modulated radiation therapy (IMRT)
Number of subjects: 132